Perioperative Immunonutrition Under Enhanced Recovery After Surgery

Phase

N/A

Condition

N/A

Treatment

Immunonutrition oral nutrition supplementation

Clinical Study ID

NCT06039306

RSCH ID-22-04215-WHE

Ages 18-80
Female

Study Summary

The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are:

is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups?
is there any difference in the post-surgical outcomes between intervention and conventional groups?

Participants (intervention) will be provided the immunonutrition supplement before and after operation.

Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Those who diagnosed with GC
Candidates for elective operation treatments

Exclusion

Exclusion Criteria:

Those are involved gastrointestinal tract (complication)
Those are diagnosed with GC (metastasis)
Allergy to milk/soy/whey protein
Participate in other intervention study

Study Design

Immunonutrition oral nutrition supplementation

September 01, 2024

October 30, 2025

Study Description

The clinical trial aims to determine the effectiveness of perioperative IMN intervention on postoperative outcomes among GC patients under Enhanced Recovery after Surgery (ERAS) setting. Patients will prescribed with immunonutrition supplement before and after surgery.

Connect with a study center

Institut Kanser Negara
Putrajaya, 62250
Malaysia
Active - Recruiting
Institut Kanser Negara (National Cancer Institute)
Putrajaya, 62250
Malaysia
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.